Home > News > AMSBIO: Cryopreserved Primary Human Cells
Industry Updates New Products Supplier News Upcoming Events business web

AMSBIO: Cryopreserved Primary Human Cells

Hits:380   Date: 1/26/2023
AMSBIO is a leading supplier of cryopreserved primary human cells for research from multiple organs including the lung, liver, intestine, and kidney. Drawing upon well-established partnerships with respected organ procurement organizations, AMSBIO has access to samples that allow direct isolation of a wide range of cells that retain their original morphological and functional characteristics.
 
Every batch of cells is validated for cell viability, morphology, plating efficiency and cell marker data. Cells are cultured for 5-7 days before being released and delivered with donor demographics and serology data demonstrating viral and mycoplasma negative status. The range of cryopreserved primary human cells from AMSBIO includes lung products (bronchial, tracheal and small airway epithelial cells, fibroblasts) ; kidney products (cortical cells, podocytes, proximal tubules, mesangial cells and glomerular endothelial cells) ; intestinal products (epithelial cells and myofibroblasts from ascending, transverse, descending colon, duodenum, jejunum and ilium) and liver products (Kupffer, stellate, sinusoidal endothelial and biliary epithelial cells and hepatocytes).

 
 

For further information on cryopreserved primary human cells for research please visit https://www.amsbio.com/human-normal-primary-cells/ or contact AMSBIO on +31-72-8080244 / +44-1235-828200 / +1-617-945-5033 / info@amsbio.com.
 
Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics, and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion, and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics. For drug discovery research, AMSBIO offers assays, recombinant proteins, and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognized as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications. This includes GMP cryopreservation technology, and high-quality solutions for viral delivery.

---------------------

Worldwide HQ

AMS Biotechnology (AMSBIO)
184 Milton Park
Abingdon
Oxon OX14 4SE
UK
Tel: +44-1235-828200
Fax: +44-1235-820482
Email: 
info@amsbio.com
Web www.amsbio.com
 
North American HQ
AMSBIO LLC
1035 Cambridge Street
Cambridge
MA 02141
USA
Tel: +1.617.945.5033
Tel: +1.800.987.0985 (toll free)
Email: info@amsbio.com
Web: www.amsbio.com
AMSBIO
Tel:+44 (0) 1235 828 200
E-mail:info@amsbio.com